Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats

ISSN:
1573-2630
Keywords:
piroxicam ; streptozocin ; blood-retina barrier ; vitreous fluorophotometry ; platelet aggregation
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The effect of piroxicam on the blood-retina barrier was evaluated in rats with experimentally induced diabetes. Diabetes was induced in rats by intraperitoneal injection of streptozocin (STZ). Diabetic rats were divided into two equal groups: those treated with piroxicam, a long-acting platelet inhibitor, and an untreated control group. Vitreous fluorophotometry (VFP) was performed both before and two weeks after induction of diabetes and piroxicam intake. Streptozocin-induced diabetes caused an alteration in the blood-retinal barrier evidenced by an increase in vitreous fluorescein concentration in diabetic rats compared with normal rats. Piroxicam intake did not lead to significant change in vitreous fluorescein concentrations. However, the examination had to be terminated at two weeks because of cataract formation. The piroxicam treated group showed less incidence of lens opacity formation (59.1% compared to 81.8% in the untreated group, p = 0.0006). Piroxicam administration appears to protect the diabetic rat eye against lens opacification.
Type of Medium:
Electronic Resource
URL:
_version_ 1798296653770260482
autor Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
autorsonst Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
book_url http://dx.doi.org/10.1007/BF00128953
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM194443655
issn 1573-2630
journal_name International ophthalmology
materialart 1
notes Abstract The effect of piroxicam on the blood-retina barrier was evaluated in rats with experimentally induced diabetes. Diabetes was induced in rats by intraperitoneal injection of streptozocin (STZ). Diabetic rats were divided into two equal groups: those treated with piroxicam, a long-acting platelet inhibitor, and an untreated control group. Vitreous fluorophotometry (VFP) was performed both before and two weeks after induction of diabetes and piroxicam intake. Streptozocin-induced diabetes caused an alteration in the blood-retinal barrier evidenced by an increase in vitreous fluorescein concentration in diabetic rats compared with normal rats. Piroxicam intake did not lead to significant change in vitreous fluorescein concentrations. However, the examination had to be terminated at two weeks because of cataract formation. The piroxicam treated group showed less incidence of lens opacity formation (59.1% compared to 81.8% in the untreated group, p = 0.0006). Piroxicam administration appears to protect the diabetic rat eye against lens opacification.
package_name Springer
publikationsjahr_anzeige 1991
publikationsjahr_facette 1991
publikationsjahr_intervall 8009:1990-1994
publikationsjahr_sort 1991
publisher Springer
reference 15 (1991), S. 335-341
schlagwort piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
search_space articles
shingle_author_1 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
shingle_author_2 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
shingle_author_3 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
shingle_author_4 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
shingle_catch_all_1 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
Abstract The effect of piroxicam on the blood-retina barrier was evaluated in rats with experimentally induced diabetes. Diabetes was induced in rats by intraperitoneal injection of streptozocin (STZ). Diabetic rats were divided into two equal groups: those treated with piroxicam, a long-acting platelet inhibitor, and an untreated control group. Vitreous fluorophotometry (VFP) was performed both before and two weeks after induction of diabetes and piroxicam intake. Streptozocin-induced diabetes caused an alteration in the blood-retinal barrier evidenced by an increase in vitreous fluorescein concentration in diabetic rats compared with normal rats. Piroxicam intake did not lead to significant change in vitreous fluorescein concentrations. However, the examination had to be terminated at two weeks because of cataract formation. The piroxicam treated group showed less incidence of lens opacity formation (59.1% compared to 81.8% in the untreated group, p = 0.0006). Piroxicam administration appears to protect the diabetic rat eye against lens opacification.
1573-2630
15732630
Springer
shingle_catch_all_2 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
Abstract The effect of piroxicam on the blood-retina barrier was evaluated in rats with experimentally induced diabetes. Diabetes was induced in rats by intraperitoneal injection of streptozocin (STZ). Diabetic rats were divided into two equal groups: those treated with piroxicam, a long-acting platelet inhibitor, and an untreated control group. Vitreous fluorophotometry (VFP) was performed both before and two weeks after induction of diabetes and piroxicam intake. Streptozocin-induced diabetes caused an alteration in the blood-retinal barrier evidenced by an increase in vitreous fluorescein concentration in diabetic rats compared with normal rats. Piroxicam intake did not lead to significant change in vitreous fluorescein concentrations. However, the examination had to be terminated at two weeks because of cataract formation. The piroxicam treated group showed less incidence of lens opacity formation (59.1% compared to 81.8% in the untreated group, p = 0.0006). Piroxicam administration appears to protect the diabetic rat eye against lens opacification.
1573-2630
15732630
Springer
shingle_catch_all_3 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
Abstract The effect of piroxicam on the blood-retina barrier was evaluated in rats with experimentally induced diabetes. Diabetes was induced in rats by intraperitoneal injection of streptozocin (STZ). Diabetic rats were divided into two equal groups: those treated with piroxicam, a long-acting platelet inhibitor, and an untreated control group. Vitreous fluorophotometry (VFP) was performed both before and two weeks after induction of diabetes and piroxicam intake. Streptozocin-induced diabetes caused an alteration in the blood-retinal barrier evidenced by an increase in vitreous fluorescein concentration in diabetic rats compared with normal rats. Piroxicam intake did not lead to significant change in vitreous fluorescein concentrations. However, the examination had to be terminated at two weeks because of cataract formation. The piroxicam treated group showed less incidence of lens opacity formation (59.1% compared to 81.8% in the untreated group, p = 0.0006). Piroxicam administration appears to protect the diabetic rat eye against lens opacification.
1573-2630
15732630
Springer
shingle_catch_all_4 Bahgat, Mostafa
Anis, Hossam H.
Peyman, Gholam A.
Farahat, Hassan G.
Parry, Gareth J.
Khoobehi, Bahram
Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
piroxicam
streptozocin
blood-retina barrier
vitreous fluorophotometry
platelet aggregation
Abstract The effect of piroxicam on the blood-retina barrier was evaluated in rats with experimentally induced diabetes. Diabetes was induced in rats by intraperitoneal injection of streptozocin (STZ). Diabetic rats were divided into two equal groups: those treated with piroxicam, a long-acting platelet inhibitor, and an untreated control group. Vitreous fluorophotometry (VFP) was performed both before and two weeks after induction of diabetes and piroxicam intake. Streptozocin-induced diabetes caused an alteration in the blood-retinal barrier evidenced by an increase in vitreous fluorescein concentration in diabetic rats compared with normal rats. Piroxicam intake did not lead to significant change in vitreous fluorescein concentrations. However, the examination had to be terminated at two weeks because of cataract formation. The piroxicam treated group showed less incidence of lens opacity formation (59.1% compared to 81.8% in the untreated group, p = 0.0006). Piroxicam administration appears to protect the diabetic rat eye against lens opacification.
1573-2630
15732630
Springer
shingle_title_1 Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
shingle_title_2 Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
shingle_title_3 Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
shingle_title_4 Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:55:31.938Z
titel Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
titel_suche Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats
topic WW-YZ
uid nat_lic_papers_NLM194443655